402 Views
Category: Treatment of Antimicrobial Resistant Infections
Poster Session: Treatment of Antimicrobial Resistant Infections
Lucinda J. Van Anglen
VP of Clinical Pharmacy & Research
Healix Infusion Therapy, LLC
Sugar Land, Texas
Disclosure: Merck & Co. (Grant/Research Support)
Ramesh V. Nathan
Partner
Los Robles Health System
Thousand Oaks, California
Disclosure: Merck & Co. (Other Financial or Material Support, Grant Steering Committee Member)
Brian S. Metzger
Partner
Austin Infectious Disease Consultants
Austin, Texas
Disclosure: Allergan (Speaker's Bureau)Cumberland (Speaker's Bureau)Melinta (Speaker's Bureau)
Quyen Luu
Owner
Central Georgia Infectious Disease Associates, LLC
Macon, Georgia
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Claudia P. Schroeder
Clincal Research Lead
Healix Infusion Therapy, LLC
Sugar Land, Texas
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.